175 related articles for article (PubMed ID: 18444627)
1. Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm.
Zaheer-ul H; Uddin R; Yuan H; Petukhov PA; Choudhary MI; Madura JD
J Chem Inf Model; 2008 May; 48(5):1092-103. PubMed ID: 18444627
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease.
Kundaikar HS; Agre NP; Degani MS
Curr Comput Aided Drug Des; 2014; 10(4):335-48. PubMed ID: 25794302
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
4. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
Patel PD; Patel MR; Kaushik-Basu N; Talele TT
J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
[TBL] [Abstract][Full Text] [Related]
6. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
Jiang YR; Yang YY; Chen YL; Liang ZJ
Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
[TBL] [Abstract][Full Text] [Related]
7. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
8. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
9. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
Kumar V; De P; Ojha PK; Saha A; Roy K
Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
[TBL] [Abstract][Full Text] [Related]
10. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
11. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
Shen LL; Liu GX; Tang Y
Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
[TBL] [Abstract][Full Text] [Related]
13. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.
Ahmadi S; Ganji S
Curr Drug Discov Technol; 2016; 13(4):232-253. PubMed ID: 27457492
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
15. QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
Solomon KA; Sundararajan S; Abirami V
Molecules; 2009 Apr; 14(4):1448-55. PubMed ID: 19384276
[TBL] [Abstract][Full Text] [Related]
16. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
Sethi KK; Verma SM
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
[TBL] [Abstract][Full Text] [Related]
17. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
Lei B; Du J; Li S; Liu H; Ren Y; Yao X
J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.
Jiang YK
J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322
[TBL] [Abstract][Full Text] [Related]
19. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
Manouchehrizadeh E; Mostoufi A; Tahanpesar E; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562
[TBL] [Abstract][Full Text] [Related]
20. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]